Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?

BACKGROUND: To assess whether the clinical outcome of advanced and metastatic renal cell carcinoma (mRCC) treated with targeted therapy differs between young and old patients. PATIENTS AND METHODS: A total of 327 patients with advanced renal cell carcinoma and mRCC who received targeted therapy in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guiming, Zhu, Yao, Dong, Dahai, Gu, Weijie, Zhang, Hailiang, Sun, Lijiang, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224101/
https://www.ncbi.nlm.nih.gov/pubmed/25395863
http://dx.doi.org/10.2147/OTT.S70012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224101/
https://www.ncbi.nlm.nih.gov/pubmed/25395863
http://dx.doi.org/10.2147/OTT.S70012

Ejemplares similares